
Scandium (III) Chloride Hydrate
Properties
- We can offer items in bulk or custom. For other quantities or purities, please request a quotation.
- All prices are subject to change.
Information about Scandium (III) Chloride Hydrate / CAS 25813-71-2
Scandium (III) Chloride hydrate (ScCl₃·XH₂O) is a hygroscopic, water-soluble compound that plays an emerging role in materials research and development with emerging specialty applications in industry. Its unique properties make it valuable in materials science, catalysis, and biomedical research.
In materials science, ScCl₃·XH₂O serves as a precursor for synthesizing a variety of Scandium-containing materials. For instance, it is employed in the preparation of Scandium-modified luminescent materials, where the incorporation of Sc³⁺ ions can enhance the local site symmetries of activator ions like Er³⁺, leading to improved optical properties. Additionally, ScCl₃·XH₂O is utilized in the synthesis of Scandium-containing phosphors, which are essential components in lighting and display technologies. The incorporation of scandium enhances the luminescent properties of these materials, improving their performance in optical applications.
In catalysis, Scandium (III) Chloride hydrate functions as a Lewis acid catalyst. It has been used in the one-pot production of γ-valerolactone (GVL) from furfural, a biomass-derived platform chemical. The catalytic activity of Sc³⁺ facilitates the conversion under mild conditions, achieving significant yields without the need for additives or pretreatments. Researchers have also explored its use in organic synthesis, particularly in facilitating enantioselective reactions and promoting polymerization processes. Scandium-based catalysts have been explored for their role in polymerization processes, including modifications of Ziegler-Natta catalysts, to improve polymer yield and structural control in specialty polymer production.
In biomedical research, Scandium Chloride hydrate has been investigated for its potential role in medical imaging and radiopharmaceutical applications. Scandium isotopes derived from ScCl₃·XH₂O, such as Sc-44, have been investigated for their potential in PET imaging due to their favorable half-life and radiochemical properties. Additionally, Scandium (III) Chloride hydrate has been utilized in the development of novel drug delivery systems.
- Boyle, T. J., Cramer, R. E., Fasulo, F. A., & Padilla, N. (2021). Solvation coordination compounds of scandium chloride from the dehydration of scandium chloride hexahydrate. Polyhedron, 208, 115437.
- Ripert, V., Hubert-Pfalzgraf, L. G., & Vaissermann, J. (1999). Dehydration of scandium chloride hydrate: synthesis and molecular structures of ScCl3 (ή2-DME)(MeCN), ScCl3 (diglyme) and [Sc2 (µ-OH) 2 (H2O) 10] Cl4· 2H2O. Polyhedron, 18(13), 1845-1851.